Skip to content

Clinical trials

Waldenstrom Macroglobulinemia trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Country / region: Japan Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20132
20192
20201
20211
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3
Completed3
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
BeOne Medicines1
BeiGene1
Eli Lilly and Company1
Gilead Sciences1
Janssen Pharmaceutical K.K.1
Janssen Research & Development, LLC1
Loxo Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia9
Lymphoma, B-Cell, Marginal Zone7
Lymphoma, Follicular7
Leukemia, Lymphocytic, Chronic, B-Cell6
Lymphoma, Mantle-Cell6
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, Non-Hodgkin3
Lymphoma, B-Cell2
Bronchiolitis Obliterans Syndrome1
Dendritic Cell Sarcoma, Interdigitating1

Trials

Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.